Shares of CVS Health (CVS) surged Wednesday morning after the health in🗹surance and pharmacy giant reported better-than-expected fourth-quarter results.

CVS reported adjusted 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) of $1.19 on revenue of $97.71 billion. Analysts polled by Visible Alpha expected adjusted EPS of $0.91 on revenue of $96.89 billion.

CVS shares were up over 14% shortly after the market opened Wꦇednesday. They en♍tered the day down about 28% over the past 12 months.

Looking ahead to 2025, CVS said it expects adjusted EPS between $5.75 to $6.00, up from the $5.42 it register💖ed in 2024. Analysts were looking fꦚor $5.90.

"We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits segment," new CEO David Joyner said.

The results cap a tumultuous quarter for CVS, which saw the company 澳洲幸运5官方开奖结果体彩网:replace its CEO in October, weeks after reports emerged that it was 澳洲幸运5官方开奖结果体彩网:considering separating its retail pharmacies and Aetna health insurance operations amid struggling results and ﷽pre🦋ssure from investors.

UPDATE—This article has been updated with the latest share price information and CVS' 2025 projections.